12-6019004-C-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BA1

This summary comes from the ClinGen Evidence Repository: The missense variant NM_000552.5(VWF):c.4414G>C (p.Asp1472His) is common in the general population with Grpmax filtering allele frequency of 0.5033 in gnomAD v4.1 (based on 38011/74882 alleles in the African/African American population). This is above the threshold of >0.1 (BA1). The computational predictor REVEL gives a score of 0.188, which is below the ClinGen VWD VCEP threshold of <0.290 and does not predict a damaging effect on VWF function (BP4). Additionally, the computational splicing predictor SpliceAI does not predict an impact to splicing with this variant. This variant does appear to impact laboratory values; the mean VWF:RCo/VWF:Ag ratio of 0.75-0.82 was significantly reduced compared to 0.91-0.97 for WT in 275 healthy adult individuals harboring the Asp1472His variant (PMID:20231421). In summary this variant meets criteria to be classified as benign for von Willebrand disease based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD: BA1, BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA6402534/MONDO:0019565/090

Frequency

Genomes: 𝑓 0.21 ( 5738 hom., cov: 31)
Exomes 𝑓: 0.10 ( 11370 hom. )

Consequence

VWF
NM_000552.5 missense

Scores

18

Clinical Significance

Benign reviewed by expert panel B:13

Conservation

PhyloP100: -0.121

Publications

65 publications found
Variant links:
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
VWF Gene-Disease associations (from GenCC):
  • hereditary von Willebrand disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • von Willebrand disease type 2B
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • von Willebrand disease 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • von Willebrand disease 1
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • von Willebrand disease type 2A
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VWFNM_000552.5 linkc.4414G>C p.Asp1472His missense_variant Exon 28 of 52 ENST00000261405.10 NP_000543.3
VWFXM_047429501.1 linkc.4414G>C p.Asp1472His missense_variant Exon 28 of 52 XP_047285457.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VWFENST00000261405.10 linkc.4414G>C p.Asp1472His missense_variant Exon 28 of 52 1 NM_000552.5 ENSP00000261405.5
VWFENST00000538635.5 linkn.421-25070G>C intron_variant Intron 5 of 5 4

Frequencies

GnomAD3 genomes
AF:
0.208
AC:
31589
AN:
151844
Hom.:
5730
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.500
Gnomad AMI
AF:
0.0932
Gnomad AMR
AF:
0.127
Gnomad ASJ
AF:
0.0576
Gnomad EAS
AF:
0.116
Gnomad SAS
AF:
0.148
Gnomad FIN
AF:
0.0760
Gnomad MID
AF:
0.120
Gnomad NFE
AF:
0.0903
Gnomad OTH
AF:
0.207
GnomAD2 exomes
AF:
0.119
AC:
29448
AN:
248378
AF XY:
0.116
show subpopulations
Gnomad AFR exome
AF:
0.509
Gnomad AMR exome
AF:
0.0733
Gnomad ASJ exome
AF:
0.0597
Gnomad EAS exome
AF:
0.110
Gnomad FIN exome
AF:
0.0768
Gnomad NFE exome
AF:
0.0886
Gnomad OTH exome
AF:
0.105
GnomAD4 exome
AF:
0.104
AC:
152489
AN:
1461350
Hom.:
11370
Cov.:
99
AF XY:
0.104
AC XY:
75805
AN XY:
726966
show subpopulations
African (AFR)
AF:
0.518
AC:
17322
AN:
33468
American (AMR)
AF:
0.0798
AC:
3565
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.0582
AC:
1521
AN:
26118
East Asian (EAS)
AF:
0.108
AC:
4293
AN:
39682
South Asian (SAS)
AF:
0.146
AC:
12554
AN:
86194
European-Finnish (FIN)
AF:
0.0761
AC:
4063
AN:
53414
Middle Eastern (MID)
AF:
0.119
AC:
684
AN:
5758
European-Non Finnish (NFE)
AF:
0.0909
AC:
101083
AN:
1111674
Other (OTH)
AF:
0.123
AC:
7404
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
7211
14422
21632
28843
36054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3994
7988
11982
15976
19970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.208
AC:
31629
AN:
151962
Hom.:
5738
Cov.:
31
AF XY:
0.205
AC XY:
15247
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.500
AC:
20689
AN:
41414
American (AMR)
AF:
0.127
AC:
1940
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0576
AC:
200
AN:
3470
East Asian (EAS)
AF:
0.115
AC:
592
AN:
5136
South Asian (SAS)
AF:
0.148
AC:
711
AN:
4806
European-Finnish (FIN)
AF:
0.0760
AC:
805
AN:
10590
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.0903
AC:
6139
AN:
67956
Other (OTH)
AF:
0.205
AC:
432
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1020
2040
3059
4079
5099
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0764
Hom.:
238
Bravo
AF:
0.226
TwinsUK
AF:
0.0882
AC:
327
ALSPAC
AF:
0.0877
AC:
338
ESP6500AA
AF:
0.393
AC:
1717
ESP6500EA
AF:
0.0657
AC:
565
ExAC
AF:
0.129
AC:
15584
EpiCase
AF:
0.0910
EpiControl
AF:
0.0912

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 14, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 20, 2023
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary von Willebrand disease Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 13, 2024
ClinGen von Willebrand Disease Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The missense variant NM_000552.5(VWF):c.4414G>C (p.Asp1472His) is common in the general population with Grpmax filtering allele frequency of 0.5033 in gnomAD v4.1 (based on 38011/74882 alleles in the African/African American population). This is above the threshold of >0.1 (BA1). The computational predictor REVEL gives a score of 0.188, which is below the ClinGen VWD VCEP threshold of <0.290 and does not predict a damaging effect on VWF function (BP4). Additionally, the computational splicing predictor SpliceAI does not predict an impact to splicing with this variant. This variant does appear to impact laboratory values; the mean VWF:RCo/VWF:Ag ratio of 0.75-0.82 was significantly reduced compared to 0.91-0.97 for WT in 275 healthy adult individuals harboring the Asp1472His variant (PMID:20231421). In summary this variant meets criteria to be classified as benign for von Willebrand disease based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD: BA1, BP4. -

von Willebrand disease type 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

von Willebrand disease type 2M Benign:1
Aug 04, 2017
Versiti Diagnostic Laboratories, Versiti, Inc
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The missense variant c.4414G>C in exon 28 of the VWF gene changes aspartic acid at codon 1472 to histidine (p.D1472H). The p.D1472H variant is common in the general population (12%, Exome Aggregation Consortium) and frequently found in individuals of African descent (50%, Exome Aggregation Consortium). Although the p.D1472H variant is not thought to cause type 1 or 2M von Willebrand disease (Flood, 2010), individuals who are heterozygous or homozygous for p.D1472H may exhibit reduced ratio of VWF ristocetin cofactor activity to VWF antigen. However, p.D1472H does not have physiological consequences; specifically it does not affect VWF multimer distribution or ristocetin-independent binding of VWF to GP1b complex, and does not result in increased risk for bleeding. In summary, VWF c.4414G>C, p.D1472H, is a benign variant with respect to von Willebrand disease. -

von Willebrand disease type 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

von Willebrand disease type 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.083
DANN
Benign
0.22
DEOGEN2
Benign
0.27
T
Eigen
Benign
-2.3
Eigen_PC
Benign
-2.2
FATHMM_MKL
Benign
0.0048
N
LIST_S2
Benign
0.55
T
MetaRNN
Benign
0.000024
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.1
N
PhyloP100
-0.12
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.18
N
REVEL
Benign
0.19
Sift
Benign
0.15
T
Sift4G
Benign
0.17
T
Polyphen
0.0
B
Vest4
0.040
MPC
0.32
ClinPred
0.0065
T
GERP RS
0.81
Varity_R
0.032
gMVP
0.49
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800383; hg19: chr12-6128170; COSMIC: COSV54620580; COSMIC: COSV54620580; API